ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The T-cell-specific cell-surface receptors CD28 and CTLA-4 are important regulators of the immune system. CD28 potently enhances those T-cell functions that are essential for an effective antigen-specific immune response, and the homologous CTLA-4 counterbalances the CD28-mediated signals and thus prevents an otherwise fatal overstimulation of the lymphoid system. Here we report the identification of a third member of this family of molecules, inducible co-stimulator (ICOS), which is a homodimeric protein of relative molecular mass 55,000-60,000 (M(r) 55K-60K). Matching CD28 in potency, ICOS enhances all basic T-cell responses to a foreign antigen, namely proliferation, secretion of lymphokines, upregulation of molecules that mediate cell-cell interaction, and effective help for antibody secretion by B cells. Unlike the constitutively expressed CD28, ICOS has to be de novo induced on the T-cell surface, does not upregulate the production of interleukin-2, but superinduces the synthesis of interleukin-10, a B-cell-differentiation factor. In vivo, ICOS is highly expressed on tonsillar T cells, which are closely associated with B cells in the apical light zone of germinal centres, the site of terminal B-cell maturation. Our results indicate that ICOS is another major regulator of the adaptive immune system.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Immune co-stimulator (ICOS) is a co-stimulatory molecule expressed on T cells, which enhances function and expansion of CD8+ T cells and Tregs (Fu et al., 2011; Hutloff et al., 1999; Liakou et al., 2008).”
From Hallmarks of response, resistance, and toxicity to immune checkpoint blockade (2021) · cites this paper as Hutloff et al., 1999
Citations
Cites
Cordell, J. L., Falini, B., Erber, W. N., Ghosh, A. K., Abdulaziz, Z., MacDonald, S., Pulford, K. A., Stein, H., & Mason, D. Y. (1984) · Journal of Histochemistry & Cytochemistry · doi:10.1177/32.2.6198355 · Cited by 3,148
Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914
Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., & Mak, T. W. (1995) · Science · doi:10.1126/science.270.5238.985 · Cited by 2,766
CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717
The Immunoglobulin Superfamily: Domains For Cell Surface Recognition
Williams, A. (1988) · Annual Review of Immunology · doi:10.1146/annurev.immunol.6.1.381 · Cited by 2,254
CTLA-4 can function as a negative regulator of T cell activation
Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., & Bluestone, J. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90071-x · Cited by 2,222
MacLennan, I. C. M. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.117 · Cited by 1,729
A new member of the immunoglobulin superfamily—CTLA-4
Brunet, J.-F., Denizot, F., Luciani, M.-F., Roux-Dosseto, M., Suzan, M., Mattei, M.-G., & Golstein, P. (1987) · Nature · doi:10.1038/328267a0 · Cited by 1,306
Differential T Cell Costimulatory Requirements in CD28-Deficient Mice
Shahinian, A., Pfeffer, K., Lee, K. P., Kündig, T. M., Kishihara, K., Wakeham, A., Kawai, K., Ohashi, P. S., Thompson, C. B., & Mak, T. W. (1993) · Science · doi:10.1126/science.7688139 · Cited by 1,257
Rosenfeld, J., Capdevielle, J., Guillemot, J. C., & Ferrara, P. (1992) · Analytical Biochemistry · doi:10.1016/0003-2697(92)90061-b · Cited by 1,239 · cited 1×
“Protein material from five gels was pooled, in situ -digested with trypsi”
Method
Cited by
Items 401–500 of 1,001
REVIEW ARTICLE: B7 Family Molecules as Regulators of the Maternal Immune System in Pregnancy
Petroff, M. G., & Perchellet, A. (2010) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2010.00841.x · Cited by 75
Davis, P. M., Nadler, S. G., Stetsko, D. K., & Suchard, S. J. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.08.019 · Cited by 67
T‐cell activation in the intestinal mucosa
Montufar‐Solis, D., Garza, T., & Klein, J. R. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00471.x · Cited by 67
Wang, W., Liu, F., Qu, H.-M., Hao, C.-F., Qu, Q., Xiong-Wang, Bao, H., & Wang, X. (2013) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2013.04.002 · Cited by 67
“ICOS plays an important role in the stimulation of IL-10 producers (Hutloff et al., 1999), and the differentiation of IL-10-producing Tr-1 cells involves STAT3 signaling (Xu et al.”
BackgroundT Cell Cosignaling Molecules in Transplantation
Ford, M. L. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.012 · Cited by 70
“Second, it has been shown that in humans but not mice CD28 1022 Immunity 44, May 17, 2016 can also bind to ICOS-L (Yao et al., 2011) (Figure 2), an interaction that remains intact in the presence of belatacept but would be inhibited by selective CD28 blockade.”
BackgroundInfluentialTANK-Binding Kinase 1-Dependent Responses in Health and Autoimmunity
Louis, C., Burns, C., & Wicks, I. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00434 · Cited by 65
Deconstructing common variable immunodeficiency by genetic analysis
Schäffer, A. A., Salzer, U., Hammarström, L. L. G., & Grimbacher, B. (2007) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2007.04.002 · Cited by 67
Wang, M., Liu, Y., Cheng, Y., Wei, Y., & Wei, X. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.12.002 · Cited by 66
Semaphorin 6D regulates the late phase of CD4 + T cell primary immune responses
O’Connor, B. P., Eun, S.-Y., Ye, Z., Zozulya, A. L., Lich, J. D., Moore, C. B., Iocca, H. A., Roney, K. E., Holl, E. K., Wu, Q. P., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803386105 · Cited by 66
Current status of immunotherapy
Suzuki, S., Ishida, T., Yoshikawa, K., & Ueda, R. (2016) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyv201 · Cited by 71
Chitnis, T., & Khoury, S. J. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.08.025 · Cited by 76
Osteopontin binds ICOSL promoting tumor metastasis
Raineri, D., Dianzani, C., Cappellano, G., Maione, F., Baldanzi, G., Iacobucci, I., Clemente, N., Baldone, G., Boggio, E. M., Gigliotti, C. L., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-01333-1 · Cited by 68
Frey, O., Meisel, J., Hutloff, A., Bonhagen, K., Bruns, L., Kroczek, R. A., Morawietz, L., & Kamradt, T. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.119164 · Cited by 65
Self-citationBone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD)
Blazar, B. R., & Murphy, W. J. (2005) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2005.1701 · Cited by 70
“The inducible expression of ICOS shortly after T cell activation suggests that ICOS may be particularly important in providing costimulatory signals to activated T cells or memory cells (Hutloff et al. 1999; Yoshinaga et al. 1999; Coyle & Gutierrez-Ramos 2001).”
BackgroundDing, H., Wu, X., Wu, J., Yagita∥, H., He, Y., Zhang, J., Ren, J., & Gao, W. (2006) · Clinical Immunology · doi:10.1016/j.clim.2005.10.017 · Cited by 68
Greenwald, R. J., McAdam, A. J., Van der Woude, D., Satoskar, A. R., & Sharpe, A. H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.991 · Cited by 68
“ICOS enhances T cell cytokine production, up-regulation of CD40 ligand, and help for Ig production by B cells (1, 4).”
BackgroundGonzalo, J.-Á., Delaney, T. A., Corcoran, J., Goodearl, A. D. J., Gutierrez‐Ramos, J. C., & Coyle, A. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.1 · Cited by 99
Rivino, L., Gruarin, P., Häringer, B., Steinfelder, S., Lozza, L., Steckel, B., Weick, A., Sugliano, E., Jarrossay, D., Kühl, A. A., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091021 · Cited by 64
Watanabe, M., Takagi, Y., Kotani, M., Hara, Y., Inamine, A., Hayashi, K., Ogawa, S., Takeda, K., Tanabe, K., & Abe, R. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5222 · Cited by 72
Receptors and ligands implicated in human T cell costimulatory processes
Leitner, J. M., Grabmeier‐Pfistershammer, K., & Steinberger, P. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.11.009 · Cited by 73
Immunomodulatory therapy for melanoma: Ipilimumab and beyond
Callahan, M. K., Postow, M. A., & Wolchok, J. D. (2013) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2012.08.006 · Cited by 70
Pawlak, E., Karabon, L., Włodarska−Polińska, I., Jedynak, A., Jonkisz, A., Tomkiewicz, A., Kornafel, J. A., Stepien, M., Pacyna, A. I. , Lebioda, A., et al. (2009) · Human Immunology · doi:10.1016/j.humimm.2009.11.006 · Cited by 64
“(IFN)– , and IFN- [5], but not IL-2 [6].”
Intercellular Adhesion Molecule 1 Is Critical for Activation of CD28-Deficient T Cells
Gaglia, J. L., Greenfield, E. A., Mattoo, A., Sharpe, A. H., Freeman, G. J., & Kuchroo, V. K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6091 · Cited by 64
EphB6 crosslinking results in costimulation of T cells
Luo, H., Yu, G., Wu, Y., & Wu, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215883 · Cited by 64
Jaffar, Z. H., Stanciu, L. A., Pandit, A., Lordan, J. L., Holgate, S. T., & Roberts, K. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.6283 · Cited by 64
Sayama, S., Nagamatsu, T., Schust, D. J., Itaoka, N., Ichikawa, M., Kawana, K., Yamashita, T., Kōzuma, S., & Fujii, T. (2013) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2013.08.001 · Cited by 63
Duhen, T. M., Pasero, C., Mallet, F., Barbarat, B., Olive, D., & Costello, R. T. (2004) · European Journal of Immunology · doi:10.1002/eji.200425598 · Cited by 63
Immunity to Pathogens Taught by Specialized Human Dendritic Cell Subsets
Geginat, J., Nizzoli, G., Paroni, M., Maglie, S., Larghi, P., Pascolo, S., & Abrignani, S. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00527 · Cited by 74
Watanabe, R., Harada, Y., Takeda, K., Takahashi, J., Ohnuki, K., Ogawa, S., Ohgai, D., Kaibara, N., Koiwai, O., Tanabe, K., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.2.1085 · Cited by 62
Hebbar, M., Jeannin, P., Magistrelli, G., Hatron, P.-Y., HACHULLA, E., Devulder, B., BONNEFOY, J.-Y., & Delneste, Y. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02427.x · Cited by 63
4-1BB: Still in the Midst of Darkness
Kwon, B., Moon, C. H., Ss, K., Seo, S. K., & Kwon, B. S. (2000) · Molecules and Cells · doi:10.1007/s10059-000-0119-0 · Cited by 63
The role of cytokines, CTLA-4 and costimulation in transplant tolerance and rejection
Dai, Z., & Lakkis, F. G. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)00008-4 · Cited by 63
Perspectives on common variable immune deficiency
Park, J. H., Resnick, E. S., & Cunningham‐Rundles, C. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06338.x · Cited by 66
Dendritic cells and humoral immunity in humans
Ueno, H., Schmitt, N., Palucka, A. K., & Banchereau, J. (2010) · Immunology and Cell Biology · doi:10.1038/icb.2010.28 · Cited by 72
Nurieva, R., Wang, J., & Sahoo, A. (2013) · Immunotherapy · doi:10.2217/imt.13.33 · Cited by 68
Targeting B7‐1 in immunotherapy
Chen, R., Ganesan, A., Okoye, I., Arutyunova, E. I., Elahi, S., Lemieux, M. J., & Barakat, K. (2019) · Medicinal Research Reviews · doi:10.1002/med.21632 · Cited by 67
Ling, V., Wu, P. W., Finnerty, H. F., Agostino, M. J., Graham, J. R., Chen, S.-J., Jussiff, J. M., Fisk, G. J., Miller, C. P., & Collins, M. A. (2001) · Genomics · doi:10.1006/geno.2001.6655 · Cited by 62
The role of ICOS and other costimulatory molecules in allergy and asthma
Coyle, A. J., & Gutierrez-Ramos, J.-C. (2004) · Springer Seminars in Immunopathology · doi:10.1007/s00281-003-0154-y · Cited by 62
Greve, B., Vijayakrishnan, L., Kubal, A., Sobel, R. A., Peterson, L. B., Wicker, L. S., & Kuchroo, V. K. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.157 · Cited by 62
Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8+ T Cells
Chowdhury, S., Kar, A., Bhowmik, D., Gautam, A., Basak, D., Sarkar, I., Ghosh, P., Sarkar, D., Deka, A., Chakraborty, P., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-4052 · Cited by 61
EphrinB1 Is Essential in T-cell-T-cell Co-operation during T-cell Activation
Yu, G., Luo, H., Wu, Y., & Wu, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410814200 · Cited by 61
Hy, W., Gc, T., & Weiner, H. L. (2009) · Lupus · doi:10.1177/0961203308100511 · Cited by 61
Banerjee, P. P., Vinay, D. S., Mathew, A., Raje, M., Parekh, V. V., Prasad, D. V. R., Kumar, A., Mitra, D., & Mishra, G. C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3507 · Cited by 61
TFH cells in bystander and cognate interactions with B cells
Wan, Z., Lin, Y., Zhao, Y., & Qi, H. (2019) · Immunological Reviews · doi:10.1111/imr.12747 · Cited by 70
Glycosylation of Immune Receptors in Cancer
Sun, R., Kim, A. M. J., & Lim, S. (2021) · Cells · doi:10.3390/cells10051100 · Cited by 65
T-cell stimulation: an abundance of B7s
Abbas, A. K., & Sharpe, A. H. (1999) · Nature Medicine · doi:10.1038/70905 · Cited by 61
Lappin, M. B., & Campbell, J. D. M. (2000) · Blood Reviews · doi:10.1054/blre.2000.0136 · Cited by 65
Guillonneau, C., Aubry, V., Renaudin, K., Séveno, C., Usal, C., Tezuka, K., & Anegón, I. (2005) · Transplantation · doi:10.1097/01.tp.0000165429.57421.d6 · Cited by 66
Tiriveedhi, V., Fleming, T. P., Goedegebuure, P. S., Naughton, M., Ma, C. X., Lockhart, C., Gao, F., Gillanders, W. E., & Mohanakumar, T. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2110-9 · Cited by 62
“ICOS is a T cell-specific surface molecule related to B7 family along with CD28 and CTLA-4.”
BackgroundInfluentialTolerogenic dendritic cells: molecular and cellular mechanisms in transplantation
Švajger, U., & Rožman, P. J. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0613336 · Cited by 67
Wikenheiser, D. J., Ghosh, D., Kennedy, B., & Stumhofer, J. S. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1403206 · Cited by 64
T follicular helper cells, interleukin-21 and systemic lupus erythematosus
Gensous, N., Schmitt, N., Richez, C., Ueno, H., & Blanco, P. (2016) · Rheumatology · doi:10.1093/rheumatology/kew297 · Cited by 68
Loss of human ICOSL results in combined immunodeficiency
Roussel, L., Landekic, M., Golizeh, M., Gavino, C., Zhong, M., Chen, J., Faubert, D., Blanchet-Cohen, A., Dansereau, L., Parent, M.-A., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20180668 · Cited by 63
“Because ICOS–ICO SL interaction has been previously shown to modulate cytokine secretion through its effects on recently activated mature T cells (Hutloff et al., 1999), we cocultured Jurkat cells, at resting state or activated by TNFα to induce ICOS expression (Fig.”
BackgroundAntigen presentation by the endothelium: a green light for antigen-specific T cell trafficking?
Marelli‐Berg, F. M., & Jarmin, S. J. (2004) · Immunology Letters · doi:10.1016/s0165-2478(04)00082-3 · Cited by 67
Villegas, E. N., Lieberman, L. A., Mason, N. J., Blass, S. L., Zediak, V. P., Peach, R., Horan, T., Yoshinaga, S. K., & Hunter, C. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.2.937 · Cited by 60
Perrin, S., & Magill, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.861471 · Cited by 61
Molecular Pathways in the Induction of Interleukin-27-Driven Regulatory Type 1 Cells
Pot, C., Apetoh, L., Awasthi, A., & Kuchroo, V. K. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0047 · Cited by 53
Suwalska, K., Pawlak, E., Karabon, L., Tomkiewicz, A., Dobosz, T., Urbaniak-Kujda, D. M., Kuliczkowski, K., Wołowiec, D., Jedynak, A., & Frydecka, I. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.01.014 · Cited by 60
“Although not constitutively expressed, ICOS is rapdly upregulated on T lymphocytes upon activation [4].”
BackgroundInfluentialSato, T., Kanai∥, T., Watanabe, M., Sakuraba, A., Okamoto, S., Nakai, T., Okazawa, A., Inoue, N., Totsuka, T., Yamazaki, M., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.12.011 · Cited by 59
Self-citationRole of ICOS pathway in autoimmune and alloimmune responses in NOD mice
Ansari, M. J., Fiorina, P., Dada, S., Guleria, I., Ueno, T., Yuan, X., Trikudanathan, S., Smith, R. N., Freeman, G. J., & Sayegh, M. H. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.07.019 · Cited by 58
Role of inherited defects decreasing Fas function in autoimmunity
Dianzani, U., Chiocchetti, A., & Ramenghi, U. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00196-6 · Cited by 61
Watanabe, M., Watanabe, S., Hara, Y., Harada, Y., Kubo, M., Tanabe, K., Toma, H., & Abe, R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.1989 · Cited by 58
Phenotypic and genetic analyses of T‐cell‐mediated immunoregulation in patients with Type 1 diabetes
Tsutsumi, Y., Jie, X., Ihara, K., Nomura, A., Kanemitsu, S., Takada, H., & Hara, T. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01951.x · Cited by 63
Liang, B., Gee, R. J., Kashgarian, M. J., Sharpe, A. H., & Mamula, M. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.4.2322 · Cited by 58
T-Cell Costimulatory Molecules in Acute-Graft-Versus Host Disease: Therapeutic Implications
Briones, J., Novelli, S., & Sierra, J. (2010) · Bone Marrow Research · doi:10.1155/2011/976793 · Cited by 57
Clement, M., Marsden, M., Stacey, M. A., Abdul-Karim, J., Brias, S. G., Bento, D. F. C., Scurr, M. J., Ghazal, P., Weaver, C. T., Carlesso, G., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1006050 · Cited by 57
Ban, Y., & Tomer, Y. (2003) · Autoimmunity · doi:10.1080/08916930310001603037 · Cited by 57
Novel Role of Phosphatidylinositol 3-Kinase in CD28-mediated Costimulation
Harada, Y., Tanabe, E., Watanabe, R., Weiss, B. D., Matsumoto, A., Ariga, H., Koiwai, O., Fukui, Y., Kubo, M., June, C. H., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005051200 · Cited by 54
Monogenic Adult-Onset Inborn Errors of Immunity
Staels, F., Collignon, T., Betrains, A., Gerbaux, M., Willemsen, M., Humblet‐Baron, S., Liston, A., Vanderschueren, S., & Schrijvers, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.753978 · Cited by 60
“ICOS Inducible co-stimulator (ICOS) is a surface molecule on activated T-cells and is predominantly expressed on T-cells in the germinal center of secondary lymphoid tissue (47, 65).”
BackgroundGärdby, E., Wrammert, J., Schön, K., Ekman, L., Leanderson, T., & Lycke, N. Y. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.55 · Cited by 56
The CD28–B7 Family of Co-signaling Molecules
Nagai, S., & Azuma, M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9717-3_2 · Cited by 61
Sainson, R. C. A., Thotakura, A. K., Kosmač, M., Borhis, G., Parveen, N., Kimber, R., Carvalho, J. A., Henderson, S. J., Pryke, K. L., Okell, T., et al. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0034 · Cited by 57
Rujas, E., Cui, H., Sicard, T., Semesi, A., & Julien, J. (2020) · Nature Communications · doi:10.1038/s41467-020-18828-4 · Cited by 57
Common variable immunodeficiency: The power of co-stimulation
Salzer, U., & Grimbacher, B. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.07.004 · Cited by 61
T Cell Effector Subsets: Extending the Th1/Th2 Paradigm
Chtanova, T., & Mackay, C. R. (2001) · Advances in immunology · doi:10.1016/s0065-2776(01)78005-4 · Cited by 72
Bartolo, L., Afroz, S., Pan, Y., Xu, R., Williams, L., Lin, C.-F., Tanes, C., Bittinger, K. L., Friedman, E. S., Gimotty, P. A., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abn3127 · Cited by 59
“To investigate if antigen stimulation was occurring on an ongoing basis, we used ICOS as an activation marker to analyze T cell activation state (30, 38).”
MethodVasilevko, V., Ghochikyan, A., Holterman, M., & Agadjanyan, M. G. (2002) · DNA and Cell Biology · doi:10.1089/10445490252925404 · Cited by 73
Signals that drive T follicular helper cell formation
Webb, L. M. C., & Linterman, M. A. (2017) · Immunology · doi:10.1111/imm.12778 · Cited by 61
Wong, C. K., Li, P. W., & Lam, C. W. K. (2007) · Immunology Letters · doi:10.1016/j.imlet.2007.07.002 · Cited by 59
Mucosal Tolerance and Immunity: Regulating the Development of Allergic Disease and Asthma
Akbari, O., Stock, P., DeKruyff, R. H., & Umetsu, D. T. (2003) · International Archives of Allergy and Immunology · doi:10.1159/000069012 · Cited by 57
Future prospects in biologic therapy for systemic lupus erythematosus
Stohl, W. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.136 · Cited by 56
Use of Multi-Site Radiation Therapy for Systemic Disease Control
Patel, R. R., Verma, V., Barsoumian, H. B., Ning, M. S., Chun, S. G., Tang, C. Z., Chang, J. Y., Lee, P. P., Gandhi, S. J., Balter, P. A., et al. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.08.025 · Cited by 60
Hong, M. M. Y., & Vareki, S. M. (2022) · Cancers · doi:10.3390/cancers14061580 · Cited by 55
“ICOS expression has been implicated in enhancing pro-inflammatory immune responses by enhancing T-cell survival, Th2 cytokine production (IL-4, IL-5, IL-13), and IL-2 production required for early T-cell proliferation that can be abrogated by CTLA-4 engagement [45,46].”
BackgroundChialda, L., Zhang, M., Brune, K., & Pahl, A. M. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-36 · Cited by 54
Analysis of Immune Regulatory Genes in Familial and Sporadic Graves’ Disease
Ban, Y., Concepcion, E., Villanueva, R., Greenberg, D. A., Davies, T. F., & Tomer, Y. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031693 · Cited by 54
Wassink, L., Vieira, P. L., Smits, H. H., Kingsbury, G. A., Coyle, A. J., Kapsenberg, M. L., & Wierenga, E. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.1779 · Cited by 54
Role of CD8+ lymphocytes in chronic rejection of transplanted hearts
Fischbein, M. P., Yun, J. J., Laks, H., Irie, Y., Fishbein, M. C., Bonavida, B., & Ardehali, A. A. (2002) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2002.120008 · Cited by 54
The dendritic cell in allergic airway diseases: a new player to the game
Lambrecht, B. N. (2001) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2001.01061.x · Cited by 68
Futamatsu, H. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00334-1 · Cited by 54
T cells: A proliferation of costimulatory molecules
Mueller, D. L. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00400-0 · Cited by 54
Ryu, S., Lim, M., Kim, J., & Kim, H. Y. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01022-z · Cited by 56
T Follicular Helper Cells During Immunity and Tolerance
Linterman, M. A., & Vinuesa, C. G. (2010) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(10)92009-7 · Cited by 57
Tanaka, C., Fujimoto, M., Hamaguchi, Y., Sato, S., Takehara, K., & Hasegawa, M. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27428 · Cited by 58
Soldevilla, M. M., Villanueva, H., Meraviglia-Crivelli, D., Menon, A. P., Ruiz, M., Cebollero, J., Villalba-Esparza, M., Moreno, B., Lozano, T., Llópiz, D., et al. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.07.013 · Cited by 53
“ICOS shows high homology to CD28, making it likely that its costimulatory signal could be triggered by crosslinking of the receptor as well.(13) To address this possibility, we dimerized the ICOS-binding aptamer (Apt8) (Figure S1) to convert it into an ICOS agonist (Apt8a) (Figure S2A).”
BackgroundICOS Mediates the Development of Insulin-Dependent Diabetes Mellitus in Nonobese Diabetic Mice
Hawiger, D., Tran, E., Du, W., Booth, C. J., Li, W., Dong, C., & Flavell, R. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3140 · Cited by 59
Differential Effects of Costimulatory Pathway Modulation on Corneal Allograft Survival
Watson, M. P., George, A. J. T., & Larkin, F. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-1597 · Cited by 57
“It has been shown to maintain or modulate the immune responses in primed and memory T cells, and stimulation of ICOS in response to TCR activation augments T cell proliferation.(7) Blockade of the ICOS–ICOSL pathway is effective in suppressing the function of recently activated helper T cells, resulting in inhibition…”
BackgroundCostimulation blockade and its possible future use in clinical transplantation
Snanoudj, R., Preneuf, H. D., Créput, C., Arzouk, N., Deroure, B., Beaudreuil, S., Dürrbach, A., & Charpentier, B. (2006) · Transplant International · doi:10.1111/j.1432-2277.2006.00332.x · Cited by 54
Peng, B., Ye, P., Blazar, B. R., Freeman, G. J., Rawlings, D. J., Ochs, H. D., & Miao, C. H. (2008) · Blood · doi:10.1182/blood-2008-01-128413 · Cited by 54
Master switches of T-cell activation and differentiation
Beier, K. C., Kallinich, T., & Hamelmann, E. H. (2007) · European Respiratory Journal · doi:10.1183/09031936.00094506 · Cited by 64
Self-citationIs there a common mechanism of gastrointestinal nematode expulsion?
Lawrence, C. E. (2003) · Parasite Immunology · doi:10.1046/j.1365-3024.2003.00630.x · Cited by 64
Metadata
- Authors
- Hutloff, A., Dittrich, A. M., Beier, K. C., Eljaschewitsch, B., Kraft, R., Anagnostopoulos, I., & Kroczek, R. A.
- Affiliations
- Robert Koch Institute (DE)
- Max Delbrück Center (DE)
- Freie Universität Berlin (DE)
- Corresponding author
- Kroczek, Richard A.
- Venue
- Nature
- Published
- 1999-01
- Volume
- 397
- Issue
- 6716
- Pages
- 263-266
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1661441964
- Cited by
- 1,482
- References
- 30
- Citations by year
- 2026: 28 · 2025: 38 · 2024: 52 · 2023: 41 · 2022: 66 · 2021: 54 · 2020: 60 · 2019: 53 · 2018: 52 · 2017: 32 · 2016: 44 · 2015: 41 · 2014: 35 · 2013: 53 · 2012: 47
- FWCI
- 22.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- ICOS, CD28, CTLA-4, T cell costimulation, T cell proliferation, lymphokine secretion, IL-10, B cell help, germinal center, adaptive immune regulation
- MeSH terms
- Amino Acid Sequence, Animals, Antibodies, Monoclonal, Antigens, Differentiation, T-Lymphocyte, Cell Communication, Cell Line, Cloning, Molecular, Humans, Lymphocyte Activation, Mice, Inbred BALB C, Molecular Sequence Data, T-Lymphocytes, CD28 Antigens, Germinal Center, Mice, Inducible T-Cell Co-Stimulator Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.